Charles & Colvard (Nasdaq:CTHR) - Cotización, noticias y análisis

Resumen de acción CTHR

Charles & Colvard, Ltd. opera como empresa de joyería fina en Estados Unidos y a escala internacional.

CTHR fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Recompensas

Análisis de riesgos

Tiene menos de 1 año de cash runway

Los beneficios han disminuido un 39.2% al año en los últimos 5 años

No tiene una capitalización de mercado significativa ($9M)

Volatilidad del precio de la acción en los últimos 3 meses

Competidores de Charles & Colvard, Ltd.

Delta Apparel

NYSEAM:DLA

US$9.7m

Forward Industries

NasdaqCM:FORD

US$5.3m

Southern ITS International

OTCPK:SITS

US$5.8m

JX Luxventure

NasdaqCM:JXJT

US$7.6m

Historial de precios y rendimiento

Summary of all time highs, changes and price drops for Charles & Colvard
Historical stock prices
Current Share Price	US$2.60
52 Week High	US$9.69
52 Week Low	US$2.43
Beta	0.89
1 Month Change	-26.76%
3 Month Change	-27.58%
1 Year Change	-72.89%
3 Year Change	-90.71%
5 Year Change	-85.72%
Change since IPO	-97.69%

Noticias y actualizaciones recientes

Recent updates

Charles & Colvard, Ltd.'s (NASDAQ:CTHR) Business Is Yet to Catch Up With Its Share Price

Jan 23

Charles & Colvard Is Leading The Way In 'Made, Not Mined' Jewelry - High Return Potential

May 16

Silver Ring Value Partners - Charles & Colvard: Exited In Q4

Feb 22

Charles & Colvard (NASDAQ:CTHR) Is Doing The Right Things To Multiply Its Share Price

Dec 24

Charles & Colvard: While Diamonds Are A Girl's Best Friend, They Can Be An Investor's Best Bet

Dec 01

Charles & Colvard (NASDAQ:CTHR) Shareholders Will Want The ROCE Trajectory To Continue

Aug 26

Upgrade: Analysts Just Made A Sizeable Increase To Their Charles & Colvard, Ltd. (NASDAQ:CTHR) Forecasts

May 13

Charles & Colvard, Ltd. 2021 Q3 - Results - Earnings Call Presentation

May 08

We Like These Underlying Return On Capital Trends At Charles & Colvard (NASDAQ:CTHR)

Mar 31

Charles & Colvard, Ltd. Just Beat EPS By 200%: Here's What Analysts Think Will Happen Next

Feb 06

If You Had Bought Charles & Colvard (NASDAQ:CTHR) Stock Five Years Ago, You Could Pocket A 97% Gain Today

Jan 30

Insider Buying: The Charles & Colvard, Ltd. (NASDAQ:CTHR) Independent Director Just Bought 5.1% More Shares

Nov 20

Charles & Colvard Is A Growth ESG Company Trading Below Book

Nov 17

Rentabilidad de los accionistas

	CTHR	US Luxury	Mercado US
7D	-9.0%	1.3%	1.7%
1Y	-72.9%	-3.1%	26.3%

Rentabilidad vs. Industria: Los resultados de CTHR fueron inferiores a los de la industria US Luxury, que obtuvo un rendimiento del -5.1% el año pasado.

Rentabilidad vs. Mercado: CTHR obtuvo unos resultados inferiores a los del mercado US, que fueron del 26.8% el año pasado.

Volatilidad de los precios

Is CTHR's price volatile compared to industry and market?
CTHR volatility
CTHR Average Weekly Movement	11.7%
Luxury Industry Average Movement	5.6%
Market Average Movement	5.9%
10% most volatile stocks in US Market	16.0%
10% least volatile stocks in US Market	2.8%

Precio estable de las acciones: El precio de las acciones de CTHR ha sido volátil en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de CTHR(10%) se ha mantenido estable durante el último año, pero sigue siendo superior al 75% de las acciones de US.

Acerca de la empresa

Fundada	Empleados	CEO	Página web
1995	49	Don O'Connell	www.charlesandcolvard.com

Charles & Colvard, Ltd. opera como empresa de joyería fina en Estados Unidos y a escala internacional. La empresa opera en dos segmentos, Canales en línea y Tradicional. Fabrica, comercializa y distribuye joyas de moissanita y joyas acabadas de moissanita bajo la marca Charles & Colvard Created Moissanite; y piedras preciosas de moissanita premium bajo la marca Forever One.

Resumen de fundamentos de Charles & Colvard, Ltd.

¿Cómo se comparan los beneficios e ingresos de Charles & Colvard con su capitalización de mercado?
Estadísticas fundamentales de CTHR
Capitalización bursátil	US$7.89m
Beneficios(TTM)	-US$18.29m
Ingresos (TTM)	US$23.68m

0.3x

Ratio precio-ventas (PS)

-0.4x

Ratio precio-beneficio (PE)

¿Está CTHR sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de CTHR
Ingresos	US$23.68m
Coste de los ingresos	US$16.69m
Beneficio bruto	US$6.99m
Otros gastos	US$25.28m
Beneficios	-US$18.29m

Últimos beneficios comunicados

Mar 31, 2024

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)	-6.03
Margen bruto	29.52%
Margen de beneficio neto	-77.23%
Ratio deuda/patrimonio	1.6%

¿Cómo se ha desempeñado CTHR a largo plazo?

Ver rendimiento histórico y comparativa

Resumen de acción CTHR

Recompensas

Análisis de riesgos

Competidores de Charles & Colvard, Ltd.

NYSEAM:DLA

US$9.7m

NasdaqCM:FORD

US$5.3m

OTCPK:SITS

US$5.8m

NasdaqCM:JXJT

US$7.6m

Historial de precios y rendimiento

Noticias y actualizaciones recientes

Charles & Colvard Approves 1-for-10 Reverse Split to Bring it into Compliance with Nasdaq's Minimum Bid Price Requirement for Continued Listing

Third quarter 2024 earnings released: US$0.12 loss per share (vs US$0.28 loss in 3Q 2023)

Charles & Colvard, Ltd. to Report Q3, 2024 Results on May 02, 2024

New minor risk - Share price stability

New major risk - Market cap size

Second quarter 2024 earnings released: US$0.094 loss per share (vs US$0.034 loss in 2Q 2023)

Recent updates

Charles & Colvard Approves 1-for-10 Reverse Split to Bring it into Compliance with Nasdaq's Minimum Bid Price Requirement for Continued Listing

Third quarter 2024 earnings released: US$0.12 loss per share (vs US$0.28 loss in 3Q 2023)

Charles & Colvard, Ltd. to Report Q3, 2024 Results on May 02, 2024

New minor risk - Share price stability

New major risk - Market cap size

Second quarter 2024 earnings released: US$0.094 loss per share (vs US$0.034 loss in 2Q 2023)

Charles & Colvard, Ltd. to Report Q2, 2024 Results on Feb 13, 2024

Charles & Colvard, Ltd.'s (NASDAQ:CTHR) Business Is Yet to Catch Up With Its Share Price

Insufficient new directors

Charles & Colvard Receives Notification Letter from Nasdaq Regarding Eligible for an Additional 180-Day Grace Period, or Until June 10, 2024 to Regain Compliance with the Minimum Bid Price Requirement

Charles & Colvard, Ltd. to Report Q1, 2024 Results on Nov 09, 2023

Charles & Colvard, Ltd., Annual General Meeting, Dec 14, 2023

Charles & Colvard, Ltd. to Report Q4, 2023 Results on Oct 12, 2023

Charles & Colvard, Ltd. Provides Earnings Guidance for the Fiscal Year Ended June 30, 2023

Insufficient new directors

Charles & Colvard Receives Notification Letter from Nasdaq’s Listing Qualifications Department Indicating that the Company Is Not in Compliance with Nasdaq Listing Rule 5550(a)(2)

Insider recently bought US$204k worth of stock

Third quarter 2023 earnings released: US$0.28 loss per share (vs US$0.011 profit in 3Q 2022)

Insider recently bought US$1.6m worth of stock

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Charles & Colvard, Ltd. to Report Q2, 2023 Results on Feb 02, 2023

Charles & Colvard Receives A Notification Letter from Nasdaq Regarding Minimum Bid Price

Consensus EPS estimates fall by 200%

Consensus EPS estimates fall by 200%

First quarter 2023 earnings released: US$0.029 loss per share (vs US$0.028 profit in 1Q 2022)

Charles & Colvard, Ltd. to Report Q1, 2023 Results on Nov 03, 2022

Charles & Colvard Launches Lab Grown Precious Gemstones Giving Their Conscious Fine Jewelry Bold New Color

Charles & Colvard: Lab Grown Diamonds Can Survive A Recession

Charles & Colvard, Ltd., Annual General Meeting, Nov 17, 2022

Charles & Colvard® Expands Signature Collection to Include All New Lab Grown Diamond Men's Bands

Consensus EPS estimates have been downgraded.

President exercised options and sold US$53k worth of stock

Investors Will Want Charles & Colvard's (NASDAQ:CTHR) Growth In ROCE To Persist

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Charles & Colvard Q4 2022 Earnings Preview

Charles & Colvard, Ltd. to Report Q4, 2022 Results on Sep 01, 2022

Charles & Colvard Redefines Conscious Luxury with New Lab Grown Diamond Couture Collection

Charles & Colvard Redefines Conscious Luxury with New Lab Grown Diamond Couture Collection

Charles & Colvard, Ltd.(NasdaqCM:CTHR) dropped from Russell 3000E Growth Index

Independent Chairman recently bought US$103k worth of stock

Charles & Colvard Is Leading The Way In 'Made, Not Mined' Jewelry - High Return Potential

Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Charles & Colvard, Ltd. (NasdaqCM:CTHR) announces an Equity Buyback for $5 million worth of its shares.

Price target decreased to US$3.25

Charles & Colvard, Ltd. to Report Q3, 2022 Results on May 05, 2022

Silver Ring Value Partners - Charles & Colvard: Exited In Q4

Independent Chairman exercised options to buy US$89k worth of stock.

Consensus forecasts updated

Price target decreased to US$3.25

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Charles & Colvard (NASDAQ:CTHR) Is Doing The Right Things To Multiply Its Share Price

Independent Director exercised options to buy US$466k worth of stock.

Charles & Colvard: While Diamonds Are A Girl's Best Friend, They Can Be An Investor's Best Bet

First quarter 2022 earnings released: EPS US$0.028 (vs US$0.03 in 1Q 2021)

Independent Director exercised options to buy US$246k worth of stock.

Full year 2021 earnings released: EPS US$0.44 (vs US$0.21 loss in FY 2020)

Charles & Colvard (NASDAQ:CTHR) Shareholders Will Want The ROCE Trajectory To Continue

Independent Chairman exercised options to buy US$128k worth of stock.

Investor sentiment improved over the past week